Peritoneal surface malignancies (PSMs) are usually associated with a poor prognosis.
Nonetheless, in line with advances in the management of most abdominopelvic metastatic …

Introduction Peritoneal metastases confer the worst survival amongst all sites of metastatic
colorectal cancer. The adoption of cytoreductive surgery (CRS) with hyperthermic …

Importance To date, no randomized clinical trials have investigated perioperative systemic
therapy relative to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy …

Background Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy
(HIPEC) leads to prolonged survival for selected patients with colorectal (CRC) peritoneal …

Simple Summary The peritoneum, a common metastatic site of colorectal cancer (CRC), has
a high incidence and poor prognosis that makes it difficult to diagnose early. Peritoneal …

Background This study aimed to evaluate the impact of postoperative complications on long-
term survival in patients with peritoneal metastasis (PM) arising from colorectal cancer …

Aim Peritoneal dissemination of infiltrative appendiceal tumors is a rare and poorly
understood phenomenon. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal …

Background Cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal
chemotherapy (HIPEC) is indicated for patients with peritoneal dissemination of appendiceal …

Introduction The aim of this study was to compare the outcome of patients with peritoneal
metastasis (PM) of colorectal origin treated with complete cytoreductive surgery (CRS) and …

Purpose Multimodal treatment of colorectal (CRC) peritoneal metastases (PM) includes
systemic chemotherapy (SC) and surgical cytoreduction (CRS), eventually with hyperthermic …